Military families gain pharmacy choice; PBMs lose hidden-fee leverage
H.R. 6400 — Rx ACCESS Act · Filed by Jennifer Kiggans (R-VA) · 18 cosponsors · Introduced Dec 3, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill amends the TRICARE military pharmacy program to give beneficiaries more choice in how they receive maintenance medications starting October 1, 2026, and requires the Department of Defense to ensure retail pharmacies are reimbursed fairly—at least their actual acquisition cost plus a professional dispensing fee—while prohibiting hidden fees. It also mandates annual audits by the Comptroller General to verify reimbursement rates and pharmacy network adequacy.
Why we flagged it
The bill's operative mechanism is to expand beneficiary choice in medication delivery and impose transparent, cost-based reimbursement standards on pharmacy benefit managers administering TRICARE. It is fundamentally a healthcare access and fairness measure, not a deregulation or subsidy.
What the text implies
- Reimbursement floor tied to Medicare/Medicaid rates may increase TRICARE program costs if retail pharmacy margins were previously suppressed below those benchmarks.
- Prohibition on hidden fees and retroactive adjustments removes a revenue stream for the PBM contractor, potentially affecting contract profitability and future bidding.
- Annual Comptroller General audits create ongoing transparency and accountability, but also impose administrative burden on the contractor and DoD.
- Beneficiary election right (Oct 2026) may fragment the pharmacy network if beneficiaries concentrate in lower-cost channels, affecting rural/underserved pharmacy viability despite the bill's stated concern for geographic access.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Military beneficiaries and their families gain expanded choice in medication delivery and assurance of pharmacy network stability through transparent reimbursement standards. Retail pharmacies gain protection against hidden fees and reimbursement below cost, which supports network viability and continuity of care—a direct public benefit for a defined but significant population (military families).
Who stands to gain
- retail pharmacies (reimbursement floor protection)
- military beneficiaries (expanded choice, network stability)
Named in the bill
Department of Defense, TRICARE program, Comptroller General of the United States, Centers for Medicare and Medicaid Services, pharmacy benefit manager (PBM) contractor, retail pharmacies, military beneficiaries, House Committee on Armed Services, Senate Committee on Armed Services
Where it stands
18 cosponsors: 11 Republicans, 7 Democrats.
- Dec 3, 2025 — Introduced · Congress.gov: “Introduced in House”
- Dec 3, 2025 — Referred to House Committee on Armed Services · Congress.gov: “Referred to the House Committee on Armed Services”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
6 lobbying clients named this bill on 15 disclosure filings across 4 quarters, Dec 2025 to Sep 2026. Those filings disclosed $13,977,853 in lobbying spend. A filing names 27 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 79% of bills with at least one filing.
Jennifer Kiggans, the sponsor, reported $1,461,839 in PAC receipts in the 2026 cycle. $10,500 of that came from 2 PACs tied to these lobbying clients.
- Walmart Inc — $7,240,000 on 3 filings
- The Cigna Group and Subsidiaries (formerly Cigna Corporation and Subsidiaries) — $3,490,000 on 1 filing
- National Community Pharmacists Association — $1,190,000 on 4 filings
- National Association of Chain Drug Stores — $1,090,000 on 3 filings
- Kroger Co — $750,000 on 2 filings
Lobbying Disclosure Act filings through Oct 21, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (3,803 characters) on Sep 23, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 17,910 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Dec 2025 to Sep 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Oct 21, 2026 · page rendered 2026-11-22.
- H.R. 6400 on Congress.gov
- Actions and status history
- Cosponsors (18)
- Bill text the analysis read
- Walmart Inc — LDA filing, 2026 Q1
- The Cigna Group and Subsidiaries (formerly Cigna Corporation and Subsidiaries) — LDA filing, 2026 Q1
- National Community Pharmacists Association — LDA filing, 2026 Q3
- Jennifer Kiggans — FEC candidate receipts, 2026 cycle
“Military families gain pharmacy choice; PBMs lose hidden-fee leverage” QuorumCivic. https://share.quorumcivic.app/bill/119/hr6400 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.